The Conference on Retroviruses and Opportunistic Infections (CROI) was established in 1993 to provide a forum for basic scientists and clinical investigators to present, discuss, and critique their investigations into the epidemiology and biology of human retroviruses and associated diseases. The synergy of basic science and clinical investigation has been a major contributor to the success of the meeting. CROI has facilitated the presentation of important discoveries in the field, thereby accelerating progress in HIV and AIDS research. The best and most consequential original research defines the science at CROI, including research in HIV, hepatitis viruses, SARS-CoV-2, mpox, and other viral infections and their related conditions.
CROI 2024 was held March 3-6, 2024 in Denver, Colorado and featured presentations by several Duke CFAR investigators and trainees. Please join us in congratulating the following presenters, with abstracts and posters linked below:
Philippe Rascle – Oral presentation: MHC-E Presentation Mediates SIV-Specific NK Cell Responses in SIV-Infected Rhesus Macaques
Danielle Nettere – Poster presentation: HIV-1 Coinfection Skews iNKT Cells Toward Anergy and Exhaustion in People With Hepatitis C
Song Young Oh – Poster presentation: IgG and Fc Receptor Genetic Variation Associates With Functional Antibody Responses in HVTN 108
Shanti Narayanasamy – Poster presentation: IgG Responses Are Associated With Severe Disease and Mortality in AIDS-Associated Talaromycosis
Vu Quoc Dat – Poster presentation: Triple Screening for Invasive Mycoses in Patients With Advanced HIV Disease in Vietnam
Nguyen T Hao – Poster presentation: Histoplasmosis in Advanced HIV Disease: A Multi-Center Prospective Diagnostic Validation Study
Nguyen Quang Dieu – Poster presentation: Ultra Xpert in Blood and Urine and Myco/F Lytic Blood Culture in Patients With Advanced HIV Disease
Nguyen T M Thu – Poster presentation: Clinical Relevance of the CRAG Semiquantitative Scores in CRAG-Positive People with AIDS
Valerie Yelverton – Poster presentation: Variation in Viral Load Testing and Outcomes in Telehealth HIV Care During COVID-19
Mitchell Martin – Poster presentation: Maturation Pathway of a Rhesus V3-glycan Broadly Neutralizing Antibody Lineage
Read CROI highlights from HIV.gov:
CDC’s Dr. Mermin Discusses HIV & STI Prevention Highlights from CROI 2024
Key Community Takeaways From CROI 2024
HIV Self-Test Kits and Prevention Tools: CDC’s Dr. Neblett Fanfair on 2024 CROI Highlights
HIV Treatment Research and Key Takeaways: Dr. Dieffenbach’s Final Update from CROI 2024
